Endocyte's Series C - IV Round

Endocyte raised a round of funding on October 19, 2009.

Endocyte is a biotechnology company developing receptor-targeted therapeutics or "smart drugs" for the treatment of cancer and autoimmune diseases. The Company focuses on certain types of cancer cells…

Articles about Endocyte's Series C - IV Round: